Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARA 290 for epidermal nerve fiber regrowth in sarcoidosis-associated small fiber neuropathy
NL-OMON39192Phase 2Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jul 2012
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of cibinetide in small fiber neuropathy (SFN) and sarcoidosis, sponsored by Leiden University Medical Center. Primary endpoint: Nerve biopsy results. Started Jul 2012; status: active, not recruiting.
02
Drugs
cibinetide
03
Conditions
small fiber neuropathy (SFN)sarcoidosis
Beyond the preview
Go deeper on NL-OMON39192.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39192.